JP2013542955A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013542955A5 JP2013542955A5 JP2013537733A JP2013537733A JP2013542955A5 JP 2013542955 A5 JP2013542955 A5 JP 2013542955A5 JP 2013537733 A JP2013537733 A JP 2013537733A JP 2013537733 A JP2013537733 A JP 2013537733A JP 2013542955 A5 JP2013542955 A5 JP 2013542955A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- compound
- hcv
- compound according
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40898910P | 2010-11-01 | 2010-11-01 | |
| US61/408,989 | 2010-11-01 | ||
| PCT/US2011/058404 WO2012061248A2 (en) | 2010-11-01 | 2011-10-28 | Novel specific hcv ns3 protease inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013542955A JP2013542955A (ja) | 2013-11-28 |
| JP2013542955A5 true JP2013542955A5 (OSRAM) | 2015-02-12 |
| JP5828903B2 JP5828903B2 (ja) | 2015-12-09 |
Family
ID=46025037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537733A Expired - Fee Related JP5828903B2 (ja) | 2010-11-01 | 2011-10-28 | 新規特異的ｈｃｖ ｎｓ３プロテアーゼ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8729014B2 (OSRAM) |
| EP (1) | EP2635570B1 (OSRAM) |
| JP (1) | JP5828903B2 (OSRAM) |
| CN (1) | CN103328466B (OSRAM) |
| AU (1) | AU2011323658A1 (OSRAM) |
| BR (1) | BR112013010836A2 (OSRAM) |
| CA (1) | CA2815855C (OSRAM) |
| IL (1) | IL225908A0 (OSRAM) |
| MX (1) | MX2013004906A (OSRAM) |
| WO (1) | WO2012061248A2 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012033022A2 (pt) | 2010-06-24 | 2016-12-20 | Genosciense Pharma Sas | tratamento de vírus de hepatite c relacionado a doenças utilizando hidroxicloroquina ou uma combinação de hidroxicloroquina e um agente antiviral |
| EP2635570B1 (en) | 2010-11-01 | 2017-12-13 | RFS Pharma, LLC. | Novel specific hcv ns3 protease inhibitors |
| WO2012176149A1 (en) | 2011-06-23 | 2012-12-27 | Panmed Ltd. | Treatment of hepatitis c virus |
| CN104039774A (zh) | 2012-01-12 | 2014-09-10 | Rfs制药公司 | Hcv ns3蛋白酶抑制剂 |
| UA119315C2 (uk) | 2012-07-03 | 2019-06-10 | Гіліад Фармассет Елелсі | Інгібітори вірусу гепатиту с |
| SG11201507223TA (en) | 2013-03-15 | 2015-10-29 | Gilead Sciences Inc | Macrocyclic and bicyclic inhibitors of hepatitis c virus |
| US9926295B2 (en) * | 2014-04-15 | 2018-03-27 | Cocrystal Pharma, Inc. | Potent and selective inhibitors of hepatitis C virus |
| CN105315261A (zh) * | 2014-08-04 | 2016-02-10 | 正大天晴药业集团股份有限公司 | Hcv ns3蛋白酶抑制剂的钠盐 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995000536A1 (en) | 1993-06-22 | 1995-01-05 | Fujisawa Pharmaceutical Co., Ltd. | Peptide compounds |
| CZ298749B6 (cs) | 1996-10-18 | 2008-01-16 | Vertex Pharmaceuticals Incorporated | Inhibitory serinových proteáz a farmaceutické prostředky s jejich obsahem |
| US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
| JP4806154B2 (ja) | 2000-04-03 | 2011-11-02 | バーテックス ファーマシューティカルズ インコーポレイテッド | セリンプロテアーゼ、特にｃ型肝炎ウイルスｎｓ３プロテアーゼのインヒビター |
| CA2462200A1 (en) | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| MY140680A (en) | 2002-05-20 | 2010-01-15 | Bristol Myers Squibb Co | Hepatitis c virus inhibitors |
| WO2004032827A2 (en) | 2002-05-20 | 2004-04-22 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
| BRPI0412502A (pt) | 2003-07-10 | 2006-09-19 | Achillion Pharmaceuticals Inc | derivados de ariltiouréia substituìda úteis como inibidores de replicação viral |
| KR20120090077A (ko) | 2004-01-30 | 2012-08-16 | 얀센 알 앤드 디 아일랜드 | Ｈｃｖ ｎｓ?３ 세린 프로테아제 저해제 |
| CN1984922A (zh) | 2004-05-20 | 2007-06-20 | 先灵公司 | 用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的取代脯氨酸 |
| US7323447B2 (en) | 2005-02-08 | 2008-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| WO2006111906A2 (en) | 2005-04-19 | 2006-10-26 | Philips Intellectual Property & Standards Gmbh | Illumination system comprising a red-emitting ceramic luminescence converter |
| TWI387603B (zh) | 2005-07-20 | 2013-03-01 | Merck Sharp & Dohme | Ｈｃｖ ｎｓ３蛋白酶抑制劑 |
| KR20080036598A (ko) | 2005-08-01 | 2008-04-28 | 머크 앤드 캄파니 인코포레이티드 | Ｈｃｖ ｎｓ３ 프로테아제 억제제로서의 마크로사이클릭펩티드 |
| JP2009524681A (ja) | 2006-01-27 | 2009-07-02 | フェノミックス コーポレーション | Ｃ型肝炎ウイルスセリンプロテアーゼインヒビターおよびそのための使用 |
| CN101495457A (zh) * | 2006-07-05 | 2009-07-29 | 因特蒙公司 | C型肝炎病毒复制的新颖抑制剂 |
| KR20090024834A (ko) * | 2006-07-05 | 2009-03-09 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규 억제제 |
| US7635683B2 (en) | 2006-08-04 | 2009-12-22 | Enanta Pharmaceuticals, Inc. | Quinoxalinyl tripeptide hepatitis C virus inhibitors |
| CN101553170B (zh) | 2006-11-24 | 2011-11-09 | 株式会社岛津制作所 | X射线透视摄影装置 |
| US20080287449A1 (en) | 2007-04-26 | 2008-11-20 | Deqiang Niu | Aza-tripeptide hepatitis c serine protease inhibitors |
| CA2708150A1 (en) * | 2007-12-05 | 2009-06-18 | Enanta Pharmaceuticals, Inc. | Fluorinated tripeptide hcv serine protease inhibitors |
| CA2710144A1 (en) * | 2007-12-21 | 2009-07-02 | Avila Therapeutics, Inc. | Hcv protease inhibitors and uses thereof |
| US8293705B2 (en) | 2007-12-21 | 2012-10-23 | Avila Therapeutics, Inc. | HCV protease inhibitors and uses thereof |
| KR20110005869A (ko) | 2008-04-15 | 2011-01-19 | 인터뮨, 인크. | Ｃ형 간염 바이러스 복제의 신규한 마크로사이클릭 억제제 |
| KR101781789B1 (ko) * | 2010-01-27 | 2017-09-26 | 에이비 파르마 리미티드. | C형 간염 바이러스 억제제로 사용되는 다환 헤테로사이클릭 화합물 |
| EP2635570B1 (en) | 2010-11-01 | 2017-12-13 | RFS Pharma, LLC. | Novel specific hcv ns3 protease inhibitors |
-
2011
- 2011-10-28 EP EP11838590.5A patent/EP2635570B1/en not_active Not-in-force
- 2011-10-28 JP JP2013537733A patent/JP5828903B2/ja not_active Expired - Fee Related
- 2011-10-28 CN CN201180063866.1A patent/CN103328466B/zh not_active Expired - Fee Related
- 2011-10-28 AU AU2011323658A patent/AU2011323658A1/en not_active Abandoned
- 2011-10-28 US US13/284,641 patent/US8729014B2/en not_active Expired - Fee Related
- 2011-10-28 WO PCT/US2011/058404 patent/WO2012061248A2/en not_active Ceased
- 2011-10-28 MX MX2013004906A patent/MX2013004906A/es active IP Right Grant
- 2011-10-28 CA CA2815855A patent/CA2815855C/en not_active Expired - Fee Related
- 2011-10-28 BR BR112013010836A patent/BR112013010836A2/pt not_active IP Right Cessation
-
2013
- 2013-04-23 IL IL225908A patent/IL225908A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012528161A5 (OSRAM) | ||
| JP2011528713A5 (OSRAM) | ||
| JP2013510120A5 (OSRAM) | ||
| JP2009504763A5 (OSRAM) | ||
| JP2011079828A5 (OSRAM) | ||
| JP2012504126A5 (OSRAM) | ||
| JP2019526596A5 (OSRAM) | ||
| JP2014504643A5 (OSRAM) | ||
| JP2008530096A5 (OSRAM) | ||
| JP2007535491A5 (OSRAM) | ||
| EP2368900A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| JP2012513479A5 (OSRAM) | ||
| JP2005524632A5 (OSRAM) | ||
| RU2015114543A (ru) | Способы лечения гепатита с | |
| JP2015024998A5 (OSRAM) | ||
| JP2011520906A5 (OSRAM) | ||
| JP2011515398A5 (OSRAM) | ||
| JP2010509359A5 (OSRAM) | ||
| JP2012504132A5 (OSRAM) | ||
| JP2010510233A5 (OSRAM) | ||
| JP2012516871A5 (OSRAM) | ||
| JP2012512169A5 (OSRAM) | ||
| TN2012000009A1 (en) | Pharmaceutical composition for a hepatitis c viral protease inhibitor | |
| JP2014508804A5 (OSRAM) | ||
| JP2012504632A5 (OSRAM) |